Cook Medical's peripheral stents post successful trial data
This article was originally published in Clinica
Executive Summary
A trial of the Zilver PTX drug-eluting stent (DES) developed by Cook Medical has had positive two-year results. The self-expanding Nitinol stent, which is coated with the drug paclitaxel, is designed to treat peripheral arterial disease (PAD) in the superficial femoral artery.